| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 12/22/2009 | US7635691 Use of CDP-choline for the prophylactic treatment of cerebral ischemia |
| 12/22/2009 | US7635686 Cancer treatment with a synthetic sequences |
| 12/22/2009 | US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635475 Diabody-type bispecific antibody |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2486859C Combination immediate release controlled release levodopa/carbidopa dosage forms |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2447166C Delivery of erectile dysfunction drugs through an inhalation route |
| 12/22/2009 | CA2446990C Delivery of sedative-hypnotics through an inhalation route |
| 12/22/2009 | CA2446917C Delivery of antipsychotics through an inhalation route |
| 12/22/2009 | CA2446916C Delivery of opioids through an inhalation route |
| 12/22/2009 | CA2434813C Imidazole derivatives |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2415214C Phosphotetrahydropyran compounds |
| 12/22/2009 | CA2414514C Carbamates derived from arylalkylamines |
| 12/22/2009 | CA2406081C Administration of a thiol-based chemoprotectant compound |
| 12/22/2009 | CA2395987C Improved pharmaceutical formulations |
| 12/22/2009 | CA2373909C Multilayer drug form release in the colon |
| 12/22/2009 | CA2371712C Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 12/22/2009 | CA2369587C Solubilized pharmaceutical composition for parenteral administration |
| 12/22/2009 | CA2362381C Amide compounds and medicinal use thereof |
| 12/22/2009 | CA2348395C Compositions comprising a mixture of bioflavonols |
| 12/22/2009 | CA2346847C Novel imidazoles with anti-inflammatory activity |
| 12/22/2009 | CA2345231C Pharmaceutical compositions comprising derivatives of sulphur acids |
| 12/22/2009 | CA2330976C Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/22/2009 | CA2326529C 2-(3,5-bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide |
| 12/22/2009 | CA2323607C Immunological methods to modulate myostatin in vertebrate subjects |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |
| 12/22/2009 | CA2296141C Association of two cationic dyes for use in direct dyeing of keratinic fibres |
| 12/22/2009 | CA2183555C Reproduction and utilization of functional human tissue |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/17/2009 | WO2009151712A2 Substituted phenylcyclohexylglycolates |
| 12/17/2009 | WO2009151590A2 Methods of treating cyp2d6 alternative metabolizers |
| 12/17/2009 | WO2009151116A1 Prophylactic/ameliorating or therapeutic agent for non-alcoholic steatohepatitis |
| 12/17/2009 | WO2009151098A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING β-SECRETASE-INHIBITING ACTIVITY |
| 12/17/2009 | WO2009151094A1 HUMAN β3 ADRENERGIC RECEPTOR LIGAND, AND FOOD OR PHARMACEUTICAL PRODUCT CONTAINING THE SAME |
| 12/17/2009 | WO2009151069A1 Imidazothiazole derivative having 4,7-diazaspiro[2.5]octane ring structure |
| 12/17/2009 | WO2009150902A1 Composition for external use |
| 12/17/2009 | WO2009150543A2 Conjugated vi saccharides |
| 12/17/2009 | WO2009149920A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 12/17/2009 | WO2008129308A3 Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312424 Aromatic prodrugs of propofol, compositions and uses thereof |
| 12/17/2009 | US20090312404 Cleavable Carnitine Compound |
| 12/17/2009 | US20090312392 Amino ceramide-like compounds and therapeutic methods of use |
| 12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312307 Heterocyclo inhibitors of potassium channel function |
| 12/17/2009 | US20090312263 Gene Differentially Expressed in Breast and Bladder Cancer and Encoded Polypeptides |
| 12/17/2009 | US20090312254 Long-acting polypeptides and methods of producing same |
| 12/17/2009 | US20090311708 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression |
| 12/17/2009 | US20090311329 Casein micelles for nanoencapsulation of hydrophobic compounds |
| 12/17/2009 | US20090311324 Polymer matrix, method for its production, and its use |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311297 Biocompatible Transparent Sheet, Method for Producing the Same, and Cultured Cell Sheet Used the Same Sheet |
| 12/17/2009 | US20090311295 Particles with high uniform loading of nanoparticles and methods of preparation thereof |
| 12/17/2009 | US20090311266 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 12/17/2009 | US20090311230 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 12/17/2009 | US20090311187 Methods for predicting patient response to modulation of the Co-stimulatory pathway |
| 12/17/2009 | US20090311186 Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/17/2009 | US20090311178 Pyrrolinidium derivatives as m3 muscarinic receptors |
| 12/17/2009 | DE102008029072A1 Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis |
| 12/17/2009 | CA2727859A1 SULFUR-CONTAINING HETEROCYCLIC DERIVATIVE HAVING ß-SECRETASE-INHIBITING ACTIVITY |
| 12/17/2009 | CA2727565A1 Conjugated vi saccharides |
| 12/17/2009 | CA2727272A1 Composition for external use |
| 12/17/2009 | CA2727223A1 Human .beta.3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
| 12/17/2009 | CA2722763A1 1-amino-alkylcyclohexane derivatives for the treatment of sleep disorders |
| 12/16/2009 | EP2133335A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 12/16/2009 | EP2133331A1 5-membered heterocyclic derivative and use thereof for medical purposes |
| 12/16/2009 | EP2133330A1 Atropisomer of pyrrole derivative |
| 12/16/2009 | EP2133326A1 Novel pseudoglycolipid and use thereof |
| 12/16/2009 | EP2133325A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 12/16/2009 | EP2133094A1 Pharmaceutical composition |
| 12/16/2009 | EP2133093A1 Remedy for chemotherapy-resistant cancer containing hla class i-recognizing antibody as the active ingredient and use of the same |
| 12/16/2009 | EP2133070A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 12/16/2009 | EP2131844A1 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |
| 12/16/2009 | EP1521832B1 Anti-fragilis antibody and uses thereof |
| 12/16/2009 | EP1434603B1 Method of treatment using ligand-immunogen conjugates |
| 12/16/2009 | EP1429602B1 Methods for treating disorders using plant extracts |
| 12/16/2009 | EP1425028B1 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 12/16/2009 | EP1322634B1 N-phenyl-2-pyrimidine-amine derivatives |
| 12/16/2009 | EP1147176B1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 12/16/2009 | EP0848704B2 Form iii crystalline ¬r-(r*,r*) -2-(4-fluorophenyl)-beta-delta-dihydroxy-5-(1-methyl-ethyl)-3-phenyl-4-¬(phenylamino)carbonyl -1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
| 12/16/2009 | CN101605817A Cellulose derivative and method for production thereof |
| 12/16/2009 | CN101605811A Treatment of cachexia |
| 12/16/2009 | CN101605763A Radioprotector compounds and related methods |
| 12/16/2009 | CN101602767A Preparation method of galanthamine |
| 12/16/2009 | CN101602756A Novel compunds, pharmaceutical compositions containing same, and methods of use for same |
| 12/16/2009 | CN101602731A Metalloproteinase inhibitors |
| 12/16/2009 | CN101602730A Substituted imidazole derivative |
| 12/16/2009 | CN101601861A Chronic rheumatoid arthritis therapy containing il-6 antagonist as effective component |
| 12/16/2009 | CN101601844A Preparation method of ointment for clearing infantile tetanus neonatorium |
| 12/16/2009 | CN101601769A Medicinal composition for treating primiparous hen diseases |
| 12/16/2009 | CN101601734A Preparation method of therapeutic agent for hand and foot cryopathy |